ArQule, Inc.

ArQule, Inc.

ArQule, Inc.

Overview
Date Founded

1994

Headquarters

19 PRESIDENTIAL WAY, WOBURN, MA, 01801

Type of Company

Public

Employees (Worldwide)

51 - 100

Industries

Pharmaceuticals
Biotechnology

Company Description

ArQule, Inc. is a biopharmaceutical company. It engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA.

Contact Data
Trying to get in touch with decision makers at ArQule, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Medical Officer

Principal Accounting Officer

Senior Vice President, Program Management & Product Planning

Senior Director-Business Development

Clinical Operations Director

Associate Director

Associate Director

Senior Manager-Human Resources

Clinical Trial Manager

Board of Directors

Senior Vice President-Finance & Global Controller at Merck & Co., Inc.

Paths to ArQule, Inc.
Potential Connections via
Relationship Science
You
ArQule, Inc.
Recent Transactions
Details Hidden

Merck & Co., Inc., Merck Sharp & Dohme Corp. purchase ArQule, Inc.

Details Hidden

ArQule, Inc. issued USD Common Stock

Details Hidden

ArQule, Inc. issued USD Common Stock

Transaction Advisors
Auditor

Advised onArQule, Inc. issued USD Common Stock

Underwriter

Advised onArQule, Inc. issued USD Common Stock

Escrow Agent

Advised onArQule, Inc. issued USD Common Stock

Professional

Advised onArQule, Inc. issued USD Common Stock

Managing Director

Advised onArQule, Inc. issued USD Common Stock

Underwriter

Advised onArQule, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Attorney at Arnold & Porter LLP

Legal Advisor

Former Partner at Arnold & Porter LLP

Clients

Roivant Sciences Ltd. functions as a holding company whose subsidiaries operates as biopharmaceutical company which engages in development and commercialization of novel therapies in therapeutic area. The company is headquartered in Hamilton, Bermuda.

Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX:BSLN). Through its fully integrated research and development operations the company focuses on the development of innovative antibiotics, antifungals and oncology drugs, targeting the medical challenge of resistance and non-response to current treatment options.

Key Stats and Financials As of
Market Capitalization
$2.41B
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
$1,000 - $2,499
2012
$1,000 - $2,499
2012
Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Agios Pharmaceuticals, Inc. Pharmaceuticals - Cambridge, Massachusetts

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ArQule, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ArQule, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ArQule, Inc..